Abstract INTRODUCTION Real‐world data on lecanemab's efficacy and the longitudinal dynamics of plasma biomarkers are scarce in Chinese patients with Alzheimer's disease (AD). METHODS In this multicenter cohort study, 181 AD patients received biweekly lecanemab. Disease‐stage‐specific Clinical Dementia Rating–Sum of Box...
Limoran Tang, Xi-Chen Chen, Li Zhang et al.· Alzheimer's & Dementia· 0 citations
Overall classification performance was modest; none of the evaluated classifiers demonstrated statistically significant above-chance performance in the permutation tests, and the fNIRS features did not demonstrate statistically significant incremental predictive value beyond age and sex.
Zi-Yun Zhou, Li-Li Zhang, Shuai Zhou et al.· Journal of Visualized Experi...· 0 citations
Higher RFM was associated with greater odds of test-based cognitive impairment among United States older adults after multivariable adjustment, and the observed associations involving hypertension and physical activity status were exploratory and should not be interpreted as causal.